Faeth Therapeutics, Inc.
FTH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001829802
In the last 90 days, Faeth Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 45 institutions reported holding it in 13F filings for Q2 2026, worth $333.8M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Faeth Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 45
- +15 vs. Q1 2026
- Shares held
- 14.1M
- +11.9M (+552.6%) vs. Q1 2026
- Total value
- $333.8M
- +$265.8M (+391.1%) vs. Q1 2026
- New holders
- 22
- 17 more added
- Sold out
- 7
- 2 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $333.8M |
| Q1 2026 | 30 | $72.2M |
| Q4 2025 | 10 | $514.8K |
| Q3 2025 | 9 | $466.5K |
| Q2 2025 | 10 | $600.0K |
| Q1 2025 | 20 | $760.2K |
| Q4 2024 | 24 | $1.16M |
| Q3 2024 | 19 | $1.32M |
| Q2 2024 | 24 | $1.31M |
| Q1 2024 | 25 | $2.45M |
| Q4 2023 | 24 | $2.05M |
| Q3 2023 | 23 | $2.38M |
| Q2 2023 | 26 | $3.58M |
| Q1 2023 | 27 | $4.71M |
| Q4 2022 | 28 | $3.93M |
| Q3 2022 | 31 | $4.47M |
| Q2 2022 | 40 | $7.06M |
| Q1 2022 | 43 | $8.21M |
| Q4 2021 | 38 | $19.7M |
| Q3 2021 | 42 | $37.1M |
| Q2 2021 | 34 | $22.7M |
| Q1 2021 | 40 | $45.8M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Faeth Therapeutics, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Suvretta Capital Management, LLC | 2,020,103 | $50.5M | 1.06% | +1,985,554+5,747.1% | Added |
| Avoro Capital Advisors LLC | 1,444,039 | $36.1M | 0.32% | +1,444,039 | New |
| Baker Bros. Advisors LP | 1,286,411 | $32.2M | 0.16% | +1,286,411 | New |
| Balyasny Asset Management LLC | 1,042,198 | $26.1M | 0.05% | +1,025,993+6,331.3% | Added |
| Vivo Capital, LLC | 722,020 | $18.1M | 1.65% | 00.0% | Unchanged |
| Logos Global Management LP | 722,020 | $18.1M | 0.78% | +692,020+2,306.7% | Added |
| Ra Capital Management, L.P. | 722,020 | $18.1M | 0.16% | +722,020 | New |
| Fairmount Funds Management LLC | 722,020 | $18.1M | 1.19% | +722,020 | New |
| Caligan Partners LP | 629,467 | $15.7M | 0.76% | +503,465+399.6% | Added |
| B Group, Inc. | 610,169 | $15.3M | 8.66% | +610,169 | New |
| Trails Edge Capital Partners, LP | 515,335 | $12.9M | 2.05% | +390,335+312.3% | Added |
| Franklin Resources Inc | 494,516 | $12.4M | 0.00% | +361,010+270.4% | Added |
| Octagon Capital Advisors LP | 361,010 | $9.03M | 0.83% | +361,010 | New |
| ADAR1 Capital Management, LLC | 361,010 | $9.03M | 0.42% | +361,010 | New |
| Cormorant Asset Management, LP | 1,028,242 | $7.66M | 0.39% | +722,020+235.8% | Added |
| Marshall Wace, LLP | 206,508 | $5.16M | 0.00% | +140,778+214.2% | Added |
| Boxer Capital Management, LLC | 180,505 | $4.51M | 0.34% | +180,505 | New |
| Patient Square Capital LP | 175,050 | $4.38M | 0.68% | +175,050 | New |
| Alyeska Investment Group, L.P. | 144,404 | $3.61M | 0.01% | +144,404 | New |
| Affinity Asset Advisors, LLC | 144,404 | $3.61M | 0.18% | +144,404 | New |
| Boothbay Fund Management, LLC | 133,643 | $3.34M | 0.06% | +107,519+411.6% | Added |
| AWM Investment Company, Inc. | 111,343 | $2.78M | 0.24% | +111,343 | New |
| Richmond Investment Services, LLC | 79,731 | $1.99M | 0.63% | +79,731 | New |
| Ikarian Capital, LLC | 35,386 | $884.6K | 0.14% | +29,035+457.2% | Added |
| UBS Group AG | 21,541 | $538.5K | 0.00% | +17,012+375.6% | Added |
| Renaissance Technologies LLC | 20,416 | $510.4K | 0.00% | −11,625−36.3% | Reduced |
| Jane Street Group, LLC | 20,117 | $502.9K | 0.00% | +11,245+126.7% | Added |
| Morgan Stanley | 17,329 | $433.2K | 0.00% | +8,534+97.0% | Added |
| Catalio Capital Management, LP | 14,718 | $367.9K | 0.07% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 14,616 | $365.4K | 0.00% | +5,115+53.8% | Added |
| Superstring Capital Management LP | 14,175 | $354.4K | 0.22% | +14,175 | New |
| Barclays PLC | 12,412 | $310.3K | 0.00% | +12,412 | New |
| Citadel Advisors LLC | 12,296 | $307.4K | 0.00% | +12,296 | New |
| Vanguard Capital Management LLC | 10,115 | $252.9K | 0.00% | +2,365+30.5% | Added |
| XTX Topco Ltd | 9,608 | $240.2K | 0.00% | +9,608 | New |
| Vanguard Fiduciary Trust Co | 6,307 | $157.7K | 0.00% | 00.0% | Unchanged |
| China Universal Asset Management Co., Ltd. | 3,600 | $90.0K | 0.01% | +3,600 | New |
| BlackRock, Inc. | 3,402 | $85.0K | 0.00% | +3,402 | New |
| Tower Research Capital LLC (TRC) | 650 | $16.3K | 0.00% | −846−56.6% | Reduced |
| Royal Bank of Canada | 509 | $13.0K | 0.00% | +509 | New |
| BNP Paribas Arbitrage, SA | 113 | $2.83K | 0.00% | +104+1,155.6% | Added |
| JPMorgan Chase & Co | 40 | $929 | 0.00% | +8+25.0% | Added |
| Quarry LP | 32 | $800 | 0.00% | +32 | New |
| UMA Financial Services, Inc. | 28 | $700 | 0.00% | +28 | New |
| SBI Securities Co., Ltd. | 4 | $100 | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 0 | $0 | 0.00% | −146,565−100.0% | Sold out |
| StemPoint Capital LP | 0 | $0 | 0.00% | −132,873−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −61,568−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −58,001−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −33,025−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −20,333−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −18,337−100.0% | Sold out |